Correlation of tissue and blood plasminogen activation system in breast cancer

The plasminogen activation system plays a crucial role during cancer invasion and metastasis. In the solid tumor, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1) and uPA receptor (uPAR) are considered as prognostic factors. In this study, we have investigat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2000-03, Vol.150 (2), p.137-145
Hauptverfasser: Rha, Sun Young, Yang, Woo Ick, Gong, Soo Jung, Kim, Jin Ju, Yoo, Nae Choon, Roh, Jae Kyung, Min, Jin Sik, Lee, Kyong Sik, Kim, Byung Soo, Chung, Hyun Cheol
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 145
container_issue 2
container_start_page 137
container_title Cancer letters
container_volume 150
creator Rha, Sun Young
Yang, Woo Ick
Gong, Soo Jung
Kim, Jin Ju
Yoo, Nae Choon
Roh, Jae Kyung
Min, Jin Sik
Lee, Kyong Sik
Kim, Byung Soo
Chung, Hyun Cheol
description The plasminogen activation system plays a crucial role during cancer invasion and metastasis. In the solid tumor, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1) and uPA receptor (uPAR) are considered as prognostic factors. In this study, we have investigated whether secretion of the uPA, PAI-1 and uPAR from the primary breast cancer tissue can be detected in the blood of the patients using the ELISA assay. We have found that the plasminogen activation system (uPA, PAI-1, uPAR) of tumor tissue is activated from the early stage of breast cancer. However, only a number of metastatic lymph nodes was a prognostic factor in multivariate analysis for relapse. The blood level of the plasminogen activation system correlated with that of tissue in an order of uPAR ( r 2=0.61; P=0.001), uPA ( r 2=0.35; P=0.001) and PAI-1 ( r 2=0.11; P=0.001). We conclude that the total uPAR level of cancer tissue can be substituted by that which is detected in the blood for further clinical applications.
doi_str_mv 10.1016/S0304-3835(99)00376-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70983958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383599003766</els_id><sourcerecordid>70983958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-c8e6545fadd2869e8c387615f1ddc839e249ba7137b327a438fdb0ea7af83c933</originalsourceid><addsrcrecordid>eNqF0MtO3DAUgGGrApXh8gitvEAVLAL2OL6tUDVqCxKCBbC2HPukcpXEg08Gibdvhoxadqy8-c6x_RPyhbMLzri6fGCC1ZUwQp5Ze86Y0KpSn8iCG72stDVsjyz-kQNyiPiHMSZrLT-TA840q7WQC3K3yqVA58eUB5pbOibEDVA_RNp0OUe67jz2aci_YaA-jOllpviKI_Q0DbQp4HGkwQ8ByjHZb32HcLI7j8jTzx-Pq-vq9v7Xzer7bRWEZWMVDChZy9bHuDTKggnCaMVly2MMRlhY1rbxmgvdiKX2tTBtbBh47VsjghXiiHyb965Lft4Ajq5PGKDr_AB5g04zO62RZoJyhqFkxAKtW5fU-_LqOHPbkO4tpNtWcta6t5BOTXNfdxdsmh7iu6m53AROd8Bj8F1bpv8n_O9EzZXasquZwVTjJUFxGBJMqWIqEEYXc_rgJX8BdRiP_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70983958</pqid></control><display><type>article</type><title>Correlation of tissue and blood plasminogen activation system in breast cancer</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Rha, Sun Young ; Yang, Woo Ick ; Gong, Soo Jung ; Kim, Jin Ju ; Yoo, Nae Choon ; Roh, Jae Kyung ; Min, Jin Sik ; Lee, Kyong Sik ; Kim, Byung Soo ; Chung, Hyun Cheol</creator><creatorcontrib>Rha, Sun Young ; Yang, Woo Ick ; Gong, Soo Jung ; Kim, Jin Ju ; Yoo, Nae Choon ; Roh, Jae Kyung ; Min, Jin Sik ; Lee, Kyong Sik ; Kim, Byung Soo ; Chung, Hyun Cheol</creatorcontrib><description>The plasminogen activation system plays a crucial role during cancer invasion and metastasis. In the solid tumor, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1) and uPA receptor (uPAR) are considered as prognostic factors. In this study, we have investigated whether secretion of the uPA, PAI-1 and uPAR from the primary breast cancer tissue can be detected in the blood of the patients using the ELISA assay. We have found that the plasminogen activation system (uPA, PAI-1, uPAR) of tumor tissue is activated from the early stage of breast cancer. However, only a number of metastatic lymph nodes was a prognostic factor in multivariate analysis for relapse. The blood level of the plasminogen activation system correlated with that of tissue in an order of uPAR ( r 2=0.61; P=0.001), uPA ( r 2=0.35; P=0.001) and PAI-1 ( r 2=0.11; P=0.001). We conclude that the total uPAR level of cancer tissue can be substituted by that which is detected in the blood for further clinical applications.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(99)00376-6</identifier><identifier>PMID: 10704735</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Blood ; Breast cancer ; Breast Neoplasms - metabolism ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Enzyme-Linked Immunosorbent Assay ; Female ; Gynecology. Andrology. Obstetrics ; Host-tumor relations. Immunology. Biological markers ; Humans ; Mammary gland diseases ; Medical sciences ; Middle Aged ; PAI-1 ; Plasminogen Activator Inhibitor 1 - analysis ; Receptors, Cell Surface - analysis ; Receptors, Urokinase Plasminogen Activator ; Survival Rate ; Tissue ; Tumors ; uPA ; uPAR ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Cancer letters, 2000-03, Vol.150 (2), p.137-145</ispartof><rights>2000 Elsevier Science Ireland Ltd</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-c8e6545fadd2869e8c387615f1ddc839e249ba7137b327a438fdb0ea7af83c933</citedby><cites>FETCH-LOGICAL-c390t-c8e6545fadd2869e8c387615f1ddc839e249ba7137b327a438fdb0ea7af83c933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0304-3835(99)00376-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1341665$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10704735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rha, Sun Young</creatorcontrib><creatorcontrib>Yang, Woo Ick</creatorcontrib><creatorcontrib>Gong, Soo Jung</creatorcontrib><creatorcontrib>Kim, Jin Ju</creatorcontrib><creatorcontrib>Yoo, Nae Choon</creatorcontrib><creatorcontrib>Roh, Jae Kyung</creatorcontrib><creatorcontrib>Min, Jin Sik</creatorcontrib><creatorcontrib>Lee, Kyong Sik</creatorcontrib><creatorcontrib>Kim, Byung Soo</creatorcontrib><creatorcontrib>Chung, Hyun Cheol</creatorcontrib><title>Correlation of tissue and blood plasminogen activation system in breast cancer</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The plasminogen activation system plays a crucial role during cancer invasion and metastasis. In the solid tumor, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1) and uPA receptor (uPAR) are considered as prognostic factors. In this study, we have investigated whether secretion of the uPA, PAI-1 and uPAR from the primary breast cancer tissue can be detected in the blood of the patients using the ELISA assay. We have found that the plasminogen activation system (uPA, PAI-1, uPAR) of tumor tissue is activated from the early stage of breast cancer. However, only a number of metastatic lymph nodes was a prognostic factor in multivariate analysis for relapse. The blood level of the plasminogen activation system correlated with that of tissue in an order of uPAR ( r 2=0.61; P=0.001), uPA ( r 2=0.35; P=0.001) and PAI-1 ( r 2=0.11; P=0.001). We conclude that the total uPAR level of cancer tissue can be substituted by that which is detected in the blood for further clinical applications.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Host-tumor relations. Immunology. Biological markers</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>PAI-1</subject><subject>Plasminogen Activator Inhibitor 1 - analysis</subject><subject>Receptors, Cell Surface - analysis</subject><subject>Receptors, Urokinase Plasminogen Activator</subject><subject>Survival Rate</subject><subject>Tissue</subject><subject>Tumors</subject><subject>uPA</subject><subject>uPAR</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0MtO3DAUgGGrApXh8gitvEAVLAL2OL6tUDVqCxKCBbC2HPukcpXEg08Gibdvhoxadqy8-c6x_RPyhbMLzri6fGCC1ZUwQp5Ze86Y0KpSn8iCG72stDVsjyz-kQNyiPiHMSZrLT-TA840q7WQC3K3yqVA58eUB5pbOibEDVA_RNp0OUe67jz2aci_YaA-jOllpviKI_Q0DbQp4HGkwQ8ByjHZb32HcLI7j8jTzx-Pq-vq9v7Xzer7bRWEZWMVDChZy9bHuDTKggnCaMVly2MMRlhY1rbxmgvdiKX2tTBtbBh47VsjghXiiHyb965Lft4Ajq5PGKDr_AB5g04zO62RZoJyhqFkxAKtW5fU-_LqOHPbkO4tpNtWcta6t5BOTXNfdxdsmh7iu6m53AROd8Bj8F1bpv8n_O9EzZXasquZwVTjJUFxGBJMqWIqEEYXc_rgJX8BdRiP_g</recordid><startdate>20000331</startdate><enddate>20000331</enddate><creator>Rha, Sun Young</creator><creator>Yang, Woo Ick</creator><creator>Gong, Soo Jung</creator><creator>Kim, Jin Ju</creator><creator>Yoo, Nae Choon</creator><creator>Roh, Jae Kyung</creator><creator>Min, Jin Sik</creator><creator>Lee, Kyong Sik</creator><creator>Kim, Byung Soo</creator><creator>Chung, Hyun Cheol</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000331</creationdate><title>Correlation of tissue and blood plasminogen activation system in breast cancer</title><author>Rha, Sun Young ; Yang, Woo Ick ; Gong, Soo Jung ; Kim, Jin Ju ; Yoo, Nae Choon ; Roh, Jae Kyung ; Min, Jin Sik ; Lee, Kyong Sik ; Kim, Byung Soo ; Chung, Hyun Cheol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-c8e6545fadd2869e8c387615f1ddc839e249ba7137b327a438fdb0ea7af83c933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Host-tumor relations. Immunology. Biological markers</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>PAI-1</topic><topic>Plasminogen Activator Inhibitor 1 - analysis</topic><topic>Receptors, Cell Surface - analysis</topic><topic>Receptors, Urokinase Plasminogen Activator</topic><topic>Survival Rate</topic><topic>Tissue</topic><topic>Tumors</topic><topic>uPA</topic><topic>uPAR</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rha, Sun Young</creatorcontrib><creatorcontrib>Yang, Woo Ick</creatorcontrib><creatorcontrib>Gong, Soo Jung</creatorcontrib><creatorcontrib>Kim, Jin Ju</creatorcontrib><creatorcontrib>Yoo, Nae Choon</creatorcontrib><creatorcontrib>Roh, Jae Kyung</creatorcontrib><creatorcontrib>Min, Jin Sik</creatorcontrib><creatorcontrib>Lee, Kyong Sik</creatorcontrib><creatorcontrib>Kim, Byung Soo</creatorcontrib><creatorcontrib>Chung, Hyun Cheol</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rha, Sun Young</au><au>Yang, Woo Ick</au><au>Gong, Soo Jung</au><au>Kim, Jin Ju</au><au>Yoo, Nae Choon</au><au>Roh, Jae Kyung</au><au>Min, Jin Sik</au><au>Lee, Kyong Sik</au><au>Kim, Byung Soo</au><au>Chung, Hyun Cheol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation of tissue and blood plasminogen activation system in breast cancer</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2000-03-31</date><risdate>2000</risdate><volume>150</volume><issue>2</issue><spage>137</spage><epage>145</epage><pages>137-145</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>The plasminogen activation system plays a crucial role during cancer invasion and metastasis. In the solid tumor, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1) and uPA receptor (uPAR) are considered as prognostic factors. In this study, we have investigated whether secretion of the uPA, PAI-1 and uPAR from the primary breast cancer tissue can be detected in the blood of the patients using the ELISA assay. We have found that the plasminogen activation system (uPA, PAI-1, uPAR) of tumor tissue is activated from the early stage of breast cancer. However, only a number of metastatic lymph nodes was a prognostic factor in multivariate analysis for relapse. The blood level of the plasminogen activation system correlated with that of tissue in an order of uPAR ( r 2=0.61; P=0.001), uPA ( r 2=0.35; P=0.001) and PAI-1 ( r 2=0.11; P=0.001). We conclude that the total uPAR level of cancer tissue can be substituted by that which is detected in the blood for further clinical applications.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>10704735</pmid><doi>10.1016/S0304-3835(99)00376-6</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2000-03, Vol.150 (2), p.137-145
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_70983958
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Biological and medical sciences
Blood
Breast cancer
Breast Neoplasms - metabolism
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Enzyme-Linked Immunosorbent Assay
Female
Gynecology. Andrology. Obstetrics
Host-tumor relations. Immunology. Biological markers
Humans
Mammary gland diseases
Medical sciences
Middle Aged
PAI-1
Plasminogen Activator Inhibitor 1 - analysis
Receptors, Cell Surface - analysis
Receptors, Urokinase Plasminogen Activator
Survival Rate
Tissue
Tumors
uPA
uPAR
Urokinase-Type Plasminogen Activator - metabolism
title Correlation of tissue and blood plasminogen activation system in breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T02%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20of%20tissue%20and%20blood%20plasminogen%20activation%20system%20in%20breast%20cancer&rft.jtitle=Cancer%20letters&rft.au=Rha,%20Sun%20Young&rft.date=2000-03-31&rft.volume=150&rft.issue=2&rft.spage=137&rft.epage=145&rft.pages=137-145&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(99)00376-6&rft_dat=%3Cproquest_cross%3E70983958%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70983958&rft_id=info:pmid/10704735&rft_els_id=S0304383599003766&rfr_iscdi=true